Brevilin A |
A sesquiterpene lactone with anticancer activity; an inhibitor of STAT3 si… |
1 mg |
33993-1 |
More Info
|
Brevilin A |
A sesquiterpene lactone with anticancer activity; an inhibitor of STAT3 si… |
10 mg |
33993-10 |
More Info
|
Brevilin A |
A sesquiterpene lactone with anticancer activity; an inhibitor of STAT3 si… |
25 mg |
33993-25 |
More Info
|
Brevilin A |
A sesquiterpene lactone with anticancer activity; an inhibitor of STAT3 si… |
5 mg |
33993-5 |
More Info
|
Brexpiprazole |
A serotonin and dopamine receptor modulator; partial agonist of human 5-HT… |
10 mg |
22906-10 |
More Info
|
Brexpiprazole |
A serotonin and dopamine receptor modulator; partial agonist of human 5-HT… |
100 mg |
22906-100 |
More Info
|
Brexpiprazole |
A serotonin and dopamine receptor modulator; partial agonist of human 5-HT… |
50 mg |
22906-50 |
More Info
|
Brexpiprazole-d8 |
An internal standard for the quantification of brexpiprazole by GC- or LC-… |
1 mg |
26450-1 |
More Info
|
Brexpiprazole-d8 |
An internal standard for the quantification of brexpiprazole by GC- or LC-… |
500 µg |
26450-500 |
More Info
|
8Br-HA |
An FHIT inhibitor (IC50 = 0.12 µM); inhibits the growth of HCC827 an… |
10 mg |
34728-10 |
More Info
|
8Br-HA |
An FHIT inhibitor (IC50 = 0.12 µM); inhibits the growth of HCC827 an… |
25 mg |
34728-25 |
More Info
|
8Br-HA |
An FHIT inhibitor (IC50 = 0.12 µM); inhibits the growth of HCC827 an… |
5 mg |
34728-5 |
More Info
|
Briciclib |
An eIF4E inhibitor; inhibits proliferation of JEKO-1 and Mino MCL, MCF-7 a… |
1 mg |
22989-1 |
More Info
|
Briciclib |
An eIF4E inhibitor; inhibits proliferation of JEKO-1 and Mino MCL, MCF-7 a… |
10 mg |
22989-10 |
More Info
|
Briciclib |
An eIF4E inhibitor; inhibits proliferation of JEKO-1 and Mino MCL, MCF-7 a… |
25 mg |
22989-25 |
More Info
|
Briciclib |
An eIF4E inhibitor; inhibits proliferation of JEKO-1 and Mino MCL, MCF-7 a… |
5 mg |
22989-5 |
More Info
|
Brilliant Black BN |
A sulfonated azo dye with antiviral activity; reduces the infectivity of E… |
10 g |
34462-10 |
More Info
|
Brilliant Black BN |
A sulfonated azo dye with antiviral activity; reduces the infectivity of E… |
100 g |
34462-100 |
More Info
|
Brilliant Black BN |
A sulfonated azo dye with antiviral activity; reduces the infectivity of E… |
25 g |
34462-25 |
More Info
|
Brilliant Black BN |
A sulfonated azo dye with antiviral activity; reduces the infectivity of E… |
50 g |
34462-50 |
More Info
|
Brilliant Blue G |
A dye which stains proteins in gels with ease and sensitivity; used in the… |
25 g |
14320-25 |
More Info
|
Brilliant Blue G |
A dye which stains proteins in gels with ease and sensitivity; used in the… |
50 g |
14320-50 |
More Info
|
Brimonidine |
An α2-adrenergic receptor agonist (Kis = 2.7, 52, and 44 nM for &alp… |
100 mg |
33231-100 |
More Info
|
Brimonidine |
An α2-adrenergic receptor agonist (Kis = 2.7, 52, and 44 nM for &alp… |
250 mg |
33231-250 |
More Info
|
Brimonidine |
An α2-adrenergic receptor agonist (Kis = 2.7, 52, and 44 nM for &alp… |
50 mg |
33231-50 |
More Info
|
Brimonidine |
An α2-adrenergic receptor agonist (Kis = 2.7, 52, and 44 nM for &alp… |
500 mg |
33231-500 |
More Info
|
Brimonidine-d4 |
An internal standard for the quantification of brimonidine by GC- or LC-MS |
1 mg |
25465-1 |
More Info
|
Brimonidine-d4 |
An internal standard for the quantification of brimonidine by GC- or LC-MS |
5 mg |
25465-5 |
More Info
|
Brimonidine-d4 |
An internal standard for the quantification of brimonidine by GC- or LC-MS |
500 µg |
25465-500 |
More Info
|
Brimonidine (tartrate) |
An α2-AR agonist (Kis = 2.7, 52, and 44 nM for α2A, α2B,… |
10 mg |
15426-10 |
More Info
|
Brimonidine (tartrate) |
An α2-AR agonist (Kis = 2.7, 52, and 44 nM for α2A, α2B,… |
100 mg |
15426-100 |
More Info
|
Brimonidine (tartrate) |
An α2-AR agonist (Kis = 2.7, 52, and 44 nM for α2A, α2B,… |
25 mg |
15426-25 |
More Info
|
Brimonidine (tartrate) |
An α2-AR agonist (Kis = 2.7, 52, and 44 nM for α2A, α2B,… |
50 mg |
15426-50 |
More Info
|
5Br-INACA |
An analytical reference standard categorized as a precursor in the synthes… |
1 mg |
37881-1 |
More Info
|
5Br-INACA |
An analytical reference standard categorized as a precursor in the synthes… |
5 mg |
37881-5 |
More Info
|
Brincidofovir |
A prodrug form of cidofovir; inhibits CMV, HSV-1, HSV-2, cowpox, and vacci… |
10 mg |
35062-10 |
More Info
|
Brincidofovir |
A prodrug form of cidofovir; inhibits CMV, HSV-1, HSV-2, cowpox, and vacci… |
25 mg |
35062-25 |
More Info
|
Brincidofovir |
A prodrug form of cidofovir; inhibits CMV, HSV-1, HSV-2, cowpox, and vacci… |
5 mg |
35062-5 |
More Info
|
Brincidofovir |
A prodrug form of cidofovir; inhibits CMV, HSV-1, HSV-2, cowpox, and vacci… |
50 mg |
35062-50 |
More Info
|
Brinzolamide |
A potent carbonic anhydrase inhibitor (IC50s = 3.19 and 45.3 nM for CAII a… |
10 mg |
11660-10 |
More Info
|
Brinzolamide |
A potent carbonic anhydrase inhibitor (IC50s = 3.19 and 45.3 nM for CAII a… |
100 mg |
11660-100 |
More Info
|
Brinzolamide |
A potent carbonic anhydrase inhibitor (IC50s = 3.19 and 45.3 nM for CAII a… |
25 mg |
11660-25 |
More Info
|
Brinzolamide |
A potent carbonic anhydrase inhibitor (IC50s = 3.19 and 45.3 nM for CAII a… |
50 mg |
11660-50 |
More Info
|
Brinzolamide-d5 |
An internal standard for the quantification of brinzolamide by GC- or LC-MS |
1 mg |
30006-1 |
More Info
|
Brinzolamide-d5 |
An internal standard for the quantification of brinzolamide by GC- or LC-MS |
500 µg |
30006-500 |
More Info
|
BRITE338733 |
A RecA inhibitor (IC50 = 4.7 µM for ATP hydrolysis in a cell-free as… |
1 mg |
37302-1 |
More Info
|
BRITE338733 |
A RecA inhibitor (IC50 = 4.7 µM for ATP hydrolysis in a cell-free as… |
10 mg |
37302-10 |
More Info
|
BRITE338733 |
A RecA inhibitor (IC50 = 4.7 µM for ATP hydrolysis in a cell-free as… |
25 mg |
37302-25 |
More Info
|
BRITE338733 |
A RecA inhibitor (IC50 = 4.7 µM for ATP hydrolysis in a cell-free as… |
5 mg |
37302-5 |
More Info
|
Brivanib |
An ATP-competitive inhibitor of human VEGFR1 and 2 and FGFR1 (IC50s = 380,… |
1 mg |
23690-1 |
More Info
|